Search Results

Containing any of the words

Only of the type

Lamucon (Mycophenolate mofetil) Risk Minimization Activity

Idacio® (Adalimumab) Risk Minimization Activity

Safety Signal of Folic acid and the Risk of Constipation Safety Alert

Safety Signal of Lactulose and the Risk of Pruritus Safety Alert

Safety Signal of Sitagliptin and the Risk of Fatigue Safety Alert

Pomalidomide SPC (Pomalidomide ) Risk Minimization Activity

(WU2310) NCMDR Weakly Update Medical Report

(WU2305) NCMDR Weakly Update Medical Report

A Phase 2 Open-label, Dose Escalation Study of HST5040 in Subjects with Propionic or Methylmalonic Acidemia Followed by a 6-Month, Randomized, Double-blind, Placebo-controlled, 2-period Crossover Study and an Open-label, Long-term Extension Study Drug Clinical Trial

An open-label, controlled, multi-site, Phase 2 clinical trial to assess the ureagenesis capacity in newborns and infants up to the age of 12 months with neonatal and infantile onset of urea cycle disorders (UCD) using a 15N ammonium chloride tracer compared to newborns and infants without UCD Drug Clinical Trial